Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol)

Biomedicine and Pharmacotherapy

Volumn 60, Issue 1, 2006, Pages 5-9

  Schäfer, Angelika ^a   Chovanová, Zuzana ^b   Muchová, Jana ^b   Sumegová, Katarína ^b   Liptáková, Anna ^b   Ďuračková, Zdeňka ^b   Högger, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Cyclooxygenase; Human plasma; Pine bark extract

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PYCNOGENOL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FRENCH MARITIME PINE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; NORMAL HUMAN; PINE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROST; FLAVONOIDS; HUMANS; PINUS; PLANT BARK; PLANT EXTRACTS;

EID: 29244453202     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.08.006     Document Type: Article

References (22)

1. Maritime Pine Extract. In: United States Pharmacopeia. Rockville: United States Pharmacopeial Convention, Inc.; 2005. pp. 2115-2116.
2. P. Rohdewald A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology Int. J. Clin. Pharmacol. Ther. 40 2002 158 168
3. L. Packer, G. Rimbach, and F. Virgili Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol Free Radic. Biol. Med. 27 1999 704 724
4. G. Belcaro, M.R. Cesarone, P. Rohdewald, A. Ricci, E. Ippolito, and M. Dugall Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol Clin. Appl. Thromb. Hemost. 10 2004 373 377
5. S. Wang, D. Tang, Y. Zhao, G. Gao, X. Gao, and L. Hu The effects of Pycnogenol on the microcirculation, platelet function and ischemic myocardium in patients with coronary artery diseases Eur Bull Drug Res 7 1999 19 25
6. M. Mochizuki, and N. Hasegawa Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases Phytother. Res. 18 2004 1027 1028
7. B.H. Lau, S.K. Riesen, K.P. Truong, E.W. Lau, P. Rohdewald, and R.A. Barreta Pycnogenol as an adjunct in the management of childhood asthma J. Asthma 41 2004 825 832
8. ® in the management of asthma J. Med. Food 4 2001 201 209
9. T. Kohama, N. Suzuki, S. Ohno, and M. Inoue Analgesic efficacy of French maritime pine bark extract in dysmenorrhea: an open clinical trial J. Reprod. Med. 49 2004 828 832
10. K.G. Düweler, and P. Rohdewald Urinary metabolites of French maritime pine bark extract in humans Pharmazie 55 2000 364 368
11. T. Grimm, A. Schäfer, and P. Högger Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol) Free Radic. Biol. Med. 36 2004 811 822
12. J.A. Mitchell, P. Akarasereenont, C. Thiemermann, R.J. Flower, and J.R. Vane Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proc. Natl. Acad. Sci. USA 90 1993 11693 11697
13. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 81 2005 230S 242S
14. G. Williamson, and C. Manach Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clin. Nutr. 81 2005 243S 255S
15. H.P. Kim, K.H. Son, H.W. Chang, and S.S. Kang Anti-inflammatory plant flavonoids and cellular action mechanisms J. Pharmacol. Sci. 96 2004 229 245
16. B. Seaver, and J.R. Smith Inhibition of COX isoforms by nutraceuticals J Herb Pharmacother 4 2004 11 18
17. C. Selvam, and S.M. Jachak A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium J. Ethnopharmacol. 95 2004 209 212
18. C. Cavin, M. Delannoy, A. Malnoe, E. Debefve, A. Touche, and D. Courtois Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract Biochem. Biophys. Res. Commun. 327 2005 742 749
19. B.L. Fiebich, M. Grozdeva, S. Hess, M. Hull, U. Danesch, and A. Bodensieck Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells Planta Med. 71 2005 12 19
20. M. Murias, N. Handler, T. Erker, K. Pleban, G. Ecker, and P. Saiko Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship Bioorg. Med. Chem. 12 2004 5571 5578
21. F. Krotz, T.M. Schiele, V. Klauss, and H.Y. Sohn Selective COX-2 inhibitors and risk of myocardial infarction J. Vasc. Res. 42 2005 312 324
22. C. Saliou, G. Rimbach, H. Moini, L. McLaughlin, S. Hosseini, and J. Lee Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract Free Radic. Biol. Med. 30 2001 154 160